11 New Mexicos coverage was new as of the 2022 plan year, and the updated plan includes coverage of weight-loss medications as part of medically necessary treatment of morbid obesity and obesity. 12 Starting in 2025, North Dakota's EHB benchmark began to include coverage for weight-loss drugs, including GLP-1s for the treatment of morbid obesity
This approach focuses on sustainability rather than dramatic changes
Third, the 2-4% weight loss difference (if confirmed) may be statistically significant in studies but have little practical meaning for specific individuals
After reviewing the contents of as many books as possible, we landed on our list of favorites
Sign up for our free eBook
Namely: No longer covering GLP-1s for weight loss : Several insurers have made the choice to stop providing coverage for these drugs when used specifically for weight loss, while still covering them for other uses like diabetes